Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Don't stress about it!: Is stress management a disease-modifying therapy for multiple sclerosis?
A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy.
Early activation of CD4+ and CD8+ T lymphocytes by myelin basic protein in subjects with MS.
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis.
Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis.
Long-term effects of dalfampridine in patients with multiple sclerosis.
Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.
[The influence of locomotor treatment using robotic body-weight-supported treadmill training on rehabilitation outcome of patients suffering from neurological disorders].
Identifying autoantigens in demyelinating diseases: valuable clues to diagnosis and treatment?
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.
Animal Models in Neurology: Drawbacks and Opportunities.
The impact of environmental infections (parasites) on MS activity.
Study Suggests Targeting B Cells May Help with MS
Reproductive issues in women with multiple sclerosis: ethical considerations.
Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
Topical Application of Fingolimod Perturbs Cutaneous Inflammation.
The effect of the interval-between-sessions on prefrontal transcranial direct current stimulation (tDCS) on cognitive outcomes: a systematic review and meta-analysis.
MP2RAGE Multiple Sclerosis Magnetic Resonance Imaging at 3 T.
Detecting cortical lesions in multiple sclerosis at 7 T using white matter signal attenuation.
Neuromyelitis Optica Following Human Papillomavirus Vaccination.
Teva and Takeda announce agreement for glatiramer acetate for multiple sclerosis treatment in Japan
Complementary and alternative medicine in multiple sclerosis.
The value of specialty pharmaceuticals - a systematic review.
Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells.
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.

Pages